VentureMed Group: Valuation, Funding & Investors
VentureMed Group, Inc. is a pioneering privately held medical device company based in Minnesota dedicated to advancing endovascular solutions for arteriovenous (AV) access and peripheral arterial disease (PAD) interventions. The company's flagship technology, the FLEX Vessel Prep(TM) System, is an FDA 510(k)-cleared and CE Mark-approved device, that is designed to optimize vessel preparation using its proprietary Kinetic Endovascular Micro-incision Creation (KEMIC) technology.
Leadership & Board
- Current Number of Employees
- 37
- Current LinkedIn Followers
- 2,655
Latest Estimated Valuation
- Total Amount Raised
- $28M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $28M
- Latest Funding Round
- Series C
Company Momentum
PositiveVentureMed Group LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
VentureMed Group had 37 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
VentureMed Group had 2,655 followers as of November 16, 2026. The number of followers increased by 18 (0.68%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 29, 2025 | Series C | $28.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| S3 Ventures | Series C |
| Endeavour Vision | Series C |
Similar Companies
A snapshot of private companies similar to VentureMed Group, helping you discover and navigate related company profiles.








